Who is sponsoring NCT00502281?

NCT00502281 is sponsored by University Magna Graecia.

What condition does NCT00502281 study?

NCT00502281 studies Polycystic Ovary Syndrome.

What drugs are being tested in NCT00502281?

Interventions: highly purified urinary FSH, timed intercourses, intrauterine insemination.

What is the status of NCT00502281?

NCT00502281 is currently SUSPENDED.

Last reviewed 2013-04-05 · How we verify

Timed Intercourse Versus Intrauterine Insemination in Infertile Patients Undergoing Gonadotropin Ovarian Stimulation

NCT00502281 Phase 4 SUSPENDED

At the present the first options to induce ovulation in polycystic ovary syndrome with anovulatory infertility are clomiphene citrate (CC) and metformin. Notwithstanding the effectiveness of CC and metformin alone or in a sequential or combined regimen, a percentage of patients ranging from 5% to 30% remain anovulatory. For these patients, the use of gonadotropins for controlled ovarian stimulation (COS) is indicated. Moreover, to date it isn't clear if COS should be followed by timed intercourse (TI) or intrauterine insemination (IUI). The aim of the present study will be to compare TI and IUI in infertile PCOS patients undergoing COS in terms of cost-benefit.

Details

Lead sponsor	University Magna Graecia
Phase	Phase 4
Status	SUSPENDED
Enrolment	100
Start date	2007-01

Conditions

Polycystic Ovary Syndrome

Interventions

highly purified urinary FSH
timed intercourses, intrauterine insemination

Primary outcomes

Pregnancy rate — 3 months

Countries

Italy